{"slug":"tesamorelin-diabetic-neuropathy","verification":{"valid":true,"entries":2,"head":"617f427a9e57fb5176705311c419b78b3143406294e99f5870d57e06841046d7"},"energy":{"passes":2,"tokens_in":24041,"tokens_out":3340,"tokens_total":27381,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"617f427a9e57fb5176705311c419b78b3143406294e99f5870d57e06841046d7"},"provenance":[{"ts":"2026-06-29T23:24:04.217Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Tesamorelin for Diabetic Neuropathy\nSlug: tesamorelin-diabetic-neuropathy\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_cross\",\"condition\":\"Diabetic neuropathy\",\"condition_key\":\"diabetic-neuropathy\",\"primary_peptide\":\"tesamorelin\",\"peptides_in_scope\":[{\"id\":\"tesamorelin\",\"name\":\"Tesamorelin\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down if you have Diabetic neuropathy\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"tesamorelin\",\"name\":\"Tesamorelin\",\"section_title\":\"Why Tesamorelin might help you\",\"layer\":\"GH axis / visceral fat\",\"steps\":[\"You are reading about **Diabetic neuropathy** — what breaks down matters before any compound name.\",\"**Therefore for you:** If that layer is part of your problem, Tesamorelin is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. You are reading about **Diabetic neuropathy** — what breaks down matters before any compound name.\\n2. **Therefore for you:** If that layer is part of your problem, Tesamorelin is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **Tesamorelin** → GH axis / visceral fat\",\"section_headings\":[\"What's breaking down if you","response":"{\n  \"slug\": \"tesamorelin-diabetic-neuropathy\",\n  \"title\": \"Tesamorelin for Diabetic Neuropathy: Evidence Review\",\n  \"body\": \"## What's breaking down if you have Diabetic neuropathy\\n\\nDiabetic neuropathy involves progressive nerve damage tied to long-term high blood sugar. Layers include axonal degeneration, myelin sheath breakdown, reduced blood flow to nerves, and impaired nerve repair signals. If your condition includes these, degeneration outpaces the body's natural repair processes. The focus here stays on pathways that might support repair rather than suppress symptoms like pain.\\n\\n## Why Tesamorelin might help you\\n\\n1. You are reading about **Diabetic neuropathy** — what breaks down matters before any compound name.\\n2. **Therefore for you:** If the GH axis or visceral fat layer is part of your problem, Tesamorelin is discussed because it targets repair (tissue) — not because it masks pain.\\n\\nTesamorelin acts as a growth hormone-releasing hormone analog. It prompts the pituitary to release more growth hormone, which in turn raises IGF-1 levels. Growth hormone and IGF-1 have been linked in animal models to supporting axonal regeneration after nerve injury. If your neuropathy involves slowed nerve regrowth, this pathway could relate to repair mechanisms rather than symptom control.\\n\\nIn a human study of type 2 diabetes patients, 12 weeks of tesamorelin did not worsen insulin response, fasting glucose, or HbA1c compared to placebo (human data). This matters if metabolic stability is a concern alongside neuropathy. No direct link to nerve repair in diabetic neuropathy appears in available records.\\n\\n## How these fit together\\n\\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **Tesamorelin** → GH axis / visceral fat\\n\\nThe discussion centers on one layer only: potential support for GH-mediated tissue repair signals. No stacking details apply here.\\n\\n## What the","tokens_in":24041,"tokens_out":3340,"cost":0,"prev":"genesis","hash":"646f29e4ab0e39739507733de9ba0310116a780866493d03a638fb2d2c33b0d1"},{"ts":"2026-07-17T02:42:21.877Z","model":"owner","action":"voxel_divide","prompt":"","input":"tesamorelin-diabetic-neuropathy","response":"24 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"646f29e4ab0e39739507733de9ba0310116a780866493d03a638fb2d2c33b0d1","hash":"617f427a9e57fb5176705311c419b78b3143406294e99f5870d57e06841046d7"}]}